BE857218A - NEW PHARMACEUTICALLY ACTIVE COMPOUNDS - Google Patents
NEW PHARMACEUTICALLY ACTIVE COMPOUNDSInfo
- Publication number
- BE857218A BE857218A BE179687A BE179687A BE857218A BE 857218 A BE857218 A BE 857218A BE 179687 A BE179687 A BE 179687A BE 179687 A BE179687 A BE 179687A BE 857218 A BE857218 A BE 857218A
- Authority
- BE
- Belgium
- Prior art keywords
- active compounds
- pharmaceutically active
- new pharmaceutically
- new
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/26—Radicals substituted by sulfur atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Pyridine Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB3139176 | 1976-07-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE857218A true BE857218A (en) | 1978-01-27 |
Family
ID=10322405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE179687A BE857218A (en) | 1976-07-28 | 1977-07-27 | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS |
Country Status (15)
| Country | Link |
|---|---|
| JP (1) | JPS5315370A (en) |
| AU (1) | AU2734677A (en) |
| BE (1) | BE857218A (en) |
| CA (1) | CA1070315A (en) |
| DE (1) | DE2733953A1 (en) |
| DK (1) | DK331877A (en) |
| ES (1) | ES461100A2 (en) |
| FI (1) | FI772293A (en) |
| FR (1) | FR2359840A1 (en) |
| IL (1) | IL52544A0 (en) |
| LU (1) | LU77845A1 (en) |
| NL (1) | NL7708375A (en) |
| NO (1) | NO772668L (en) |
| PL (1) | PL107847B1 (en) |
| ZA (1) | ZA774552B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4264614A (en) | 1978-11-16 | 1981-04-28 | Glaxo Group Limited | Amine derivatives |
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57102852A (en) * | 1980-12-19 | 1982-06-26 | Shionogi & Co Ltd | Dicarboxylic acid diamide |
-
1977
- 1977-07-18 IL IL52544A patent/IL52544A0/en unknown
- 1977-07-22 DK DK331877A patent/DK331877A/en not_active Application Discontinuation
- 1977-07-26 AU AU27346/77A patent/AU2734677A/en active Pending
- 1977-07-26 LU LU77845A patent/LU77845A1/xx unknown
- 1977-07-27 BE BE179687A patent/BE857218A/en unknown
- 1977-07-27 DE DE19772733953 patent/DE2733953A1/en not_active Withdrawn
- 1977-07-27 FR FR7723079A patent/FR2359840A1/en not_active Withdrawn
- 1977-07-27 FI FI772293A patent/FI772293A/fi not_active Application Discontinuation
- 1977-07-27 ZA ZA00774552A patent/ZA774552B/en unknown
- 1977-07-27 NO NO772668A patent/NO772668L/en unknown
- 1977-07-27 CA CA283,619A patent/CA1070315A/en not_active Expired
- 1977-07-28 ES ES461100A patent/ES461100A2/en not_active Expired
- 1977-07-28 PL PL1977199908A patent/PL107847B1/en unknown
- 1977-07-28 NL NL7708375A patent/NL7708375A/en not_active Application Discontinuation
- 1977-07-28 JP JP9132477A patent/JPS5315370A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4309435A (en) | 1978-10-16 | 1982-01-05 | Imperial Chemical Industries Ltd. | Antisecretory guanidine derivatives and pharmaceutical compositions containing them |
| US4264614A (en) | 1978-11-16 | 1981-04-28 | Glaxo Group Limited | Amine derivatives |
| WO2022034121A1 (en) | 2020-08-11 | 2022-02-17 | Université De Strasbourg | H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer |
Also Published As
| Publication number | Publication date |
|---|---|
| PL107847B1 (en) | 1980-03-31 |
| CA1070315A (en) | 1980-01-22 |
| NL7708375A (en) | 1978-01-31 |
| LU77845A1 (en) | 1977-10-25 |
| PL199908A1 (en) | 1978-11-20 |
| IL52544A0 (en) | 1977-10-31 |
| FI772293A (en) | 1978-01-29 |
| ES461100A2 (en) | 1978-12-01 |
| AU2734677A (en) | 1979-02-01 |
| ZA774552B (en) | 1978-06-28 |
| FR2359840A1 (en) | 1978-02-24 |
| DE2733953A1 (en) | 1978-02-02 |
| NO772668L (en) | 1978-01-31 |
| DK331877A (en) | 1978-01-29 |
| JPS5315370A (en) | 1978-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA776129B (en) | Pharmaceutically active compounds | |
| BE854458A (en) | ANTIHYPERTENSIFY COMPOUNDS | |
| BE852223A (en) | NEW AMINOALCOYLHETEROCYCLES | |
| SE437827B (en) | HERBICIDICALLY ACTIVE ASSOCIATIONS | |
| DK206576A (en) | PHARMACOLOGICAL ACTIVE COMPOUNDS | |
| MA18631A1 (en) | NEW HETEROCYCLIC NITROGEN COMPOUNDS | |
| FR2346346A1 (en) | NEW AMINO-CHROMANOLS | |
| SE7710762L (en) | PHARMACOLOGICALLY ACTIVE ASSOCIATIONS | |
| BE824923A (en) | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| BE850941A (en) | NEW POLYPEPTIDIC COMPOUNDS | |
| FI773568A (en) | PHARMACEUTICAL PREPARATION MED LAONGTIDSVERKAN | |
| SE7702771L (en) | PHARMACOLOGICALLY ACTIVE ASSOCIATIONS | |
| BE841001A (en) | NEW PIPERIDINO COMPOUNDS | |
| DK408577A (en) | administration sets | |
| MC1156A1 (en) | CYCLIC COMPOUNDS | |
| BE857219R (en) | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| BE857220R (en) | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| BE850843A (en) | INDOLINOSPIROPYRANE COMPOUNDS | |
| NO771884L (en) | PROCEDURES FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE POLYRIBONUCLEOTIDS | |
| FI773812A (en) | PHARMACEUTICAL FORM | |
| BE857218A (en) | NEW PHARMACEUTICALLY ACTIVE COMPOUNDS | |
| BE837950A (en) | NEW PSYCHOTROPIC POLYCLIC COMPOUNDS | |
| BE861351A (en) | ALKANOYLANILIDE COMPOUNDS AND THEIR PREPARATION | |
| BE872492A (en) | NEW DIAZOIC COMPOUNDS | |
| FI773813A (en) | PHARMACEUTICAL FORM |